Primary care clinicians are often the most accessible to patients and play a crucial role in the early detection and ...

Addison’s disease is a rare condition in which the adrenal glands do not produce enough of the hormones cortisol and ...

Addison’s disease treatment market is growing with advancements in hormone replacement therapies, including glucocorticoids and mineralocorticoids, ensuring better disease management by 2035.

Glucocorticoid-induced adrenal insufficiency (GIAI) may be less common than previously expected, a Danish cross-sectional ...

The interplay between cortisol, inflammation, and disease underscores the need for effective stress management to enhance ...

Julia Anthony from SOLUtion Medical emphasizes usability and patient-centric design for the company’s dual chamber prefilled ...

Spironolactone's safety profile had been primarily generated from trials of older people with heart failure, so its safety in ...